Crossref journal-article
Oxford University Press (OUP)
The Journal of Immunology (286)
Abstract

AbstractWe have demonstrated previously that susceptibility of murine strains to the development of allergic airway responses is associated with a type 2 cytokine pattern. In the present study, we examine the in vivo role of IL-12 in the immune response to allergen exposure in susceptible (A/J) and resistant (C3H/HeJ, C3H) strains of mice. OVA sensitization and challenge induced significant increases in airway reactivity in A/J mice as compared with their PBS-challenged controls, while no increases in airway reactivity were observed in OVA-challenged C3H mice. OVA exposure of A/J mice resulted in marked increases in the Th2 cytokines, IL-4 and IL-10, in the bronchoalveolar lavage fluid, whereas increases in IFN-γ were observed in C3H mice. Strikingly, anti-IL-12 mAb (1 mg/mouse) treatment resulted in threefold increases in airway reactivity in OVA-challenged resistant C3H mice, concomitant with significant increases in bronchoalveolar lavage levels of Th2 cytokines and decreases in IFN-γ. IL-12 depletion of C3H mice also suppressed OVA-specific serum IgG2a levels and increased both serum OVA-specific IgG1 and IgE levels. Blockade of endogenous IL-12 levels in susceptible A/J mice resulted in further augmentation of type 2 immune responses. These results demonstrate that endogenous production of IL-12 is essential for resistance to Ag-induced airway hyperresponsiveness, and furthermore, that dysregulation of IL-12 production may lead to the development of deleterious type 2 immune responses to inhaled allergens.

Bibliography

Keane-Myers, A., Wysocka, M., Trinchieri, G., & Wills-Karp, M. (1998). Resistance to Antigen-Induced Airway Hyperresponsiveness Requires Endogenous Production of IL-12. The Journal of Immunology, 161(2), 919–926.

Authors 4
  1. Andrea Keane-Myers (first)
  2. Maria Wysocka (additional)
  3. Giorgio Trinchieri (additional)
  4. Marsha Wills-Karp (additional)
References 45 Referenced 49
  1. Del Prete, G. F., M. De Carli, M. M. D’Elios, P. Maestrelli, M. Ricci, L. Fabbri, S. Romagnini. 1993. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur. J. Immunol. 23: 1445 (10.1002/eji.1830230707)
  2. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. Bentley, C. Corrigan, S. Durham, B. Kay. 1992. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326: 298 (10.1056/NEJM199201303260504)
  3. Walker, C., E. Bode, L. Boer, T. Hansel, K. Blaser, J. Johann-Christian Virchow. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146: 109 (10.1164/ajrccm/146.1.109)
  4. Lopez, A. F., C. J. Sanderson, J. R. Gamble, H. R. Campbell, I. G. Young, M. A. Vadas. 1988. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J. Exp. Med. 167: 219 (10.1084/jem.167.1.219)
  5. Wang, J. M., A. Rambaldi, A. Biondi, Z. G. Chen, C. J. Sanderson, A. Montovani. 1989. Recombinant human interleukin-5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 19: 701 (10.1002/eji.1830190420)
  6. Finkelman, F. D., I. M. Katona, J. F. Urban, Jr, J. Holmes, J. Ohara, A. S. Tung, J. G. Sample, W. E. Paul. 1988. Interleukin-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 141: 2335 (10.4049/jimmunol.141.7.2335)
  7. Gavett, S. H., X. Chen, F. Finkelman, M. Wills-Karp. 1994. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10: 587 (10.1165/ajrcmb.10.6.8003337)
  8. Gavett, S. H., M. Wills-Karp. 1994. Pulmonary inflammation increases airway reactivity to acetylcholine challenge in genetically hyperresponsive, but not hyporesponsive mice. Am. J. Respir. Dis. 147: A572 (abstr.).
  9. Kuperman, D., J. Luyimbazi, M. Wills-Karp. 1996. Genetic differences in susceptibility to allergen-induced airway hyperreactivity and airway inflammation in inbred strains of mice. Am. J. Respir. Crit. Care Med. 153: A140 (abstr).
  10. Brusselle, G. G., J. C. Kips, G. Joos, H. Bluethmann, R. A. Pauwels. 1995. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am. J. Respir. Cell Mol. Biol. 12: 254 (10.1165/ajrcmb.12.3.7873190)
  11. Foster, P. S., S. P. Hogan, A. J. Ramsey, K. I. Matthaei, I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse model of asthma. J. Exp. Med. 183: 195 (10.1084/jem.183.1.195)
  12. Kung, T. T., D. M. Stelts, J. A. Zurcher, G. K. Adams, III, R. W. Egan, W. Kreutner, A. S. Watnick, H. Jones, R. W. Chapman. 1995. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am. J. Respir. Cell Mol. Biol. 13: 360 (10.1165/ajrcmb.13.3.7654390)
  13. Gavett, S. H., D. O’Hearn, C. L. Karp, B. Schofield, F. D. Finkelman, M. Wills-Karp. 1997. Blockade of the interleukin-4 receptor prevents pulmonary eosinophilia and airway hyperresponsiveness induced by antigen challenge in mice. Am. J. Physiol. 272: L253 (10.1152/ajplung.1997.272.2.L253)
  14. Hsieh, C.-S., A. B. Heimberger, J. S. Gold, A. O’Garra, K. M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell receptor transgenic system. Proc. Natl. Acad. Sci. USA 89: 6065 (10.1073/pnas.89.13.6065)
  15. Seder, R. A., W. E. Paul, M. M. Davis, B. Fazekas de St. Groth. 1992. The presence of interleukin 4 in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J. Exp. Med. 176: 1091 (10.1084/jem.176.4.1091)
  16. Hsieh, C.-S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O’Garra, K. M. Murphy. 1993. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547 (10.1126/science.8097338)
  17. Kopf, M., G. Le Gros, M. Bachman, M. C. Lamers, H. Bluethmann, G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362: 245 (10.1038/362245a0)
  18. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C.-Y. Wu, J. Ferrante, C. Stewart, U. Sarimiento, D. A. Faherty, M. K. Gately. 1996. IL-12 deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 4: 471 (10.1016/S1074-7613(00)80413-6)
  19. Reiner, S. L., R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13: 151 (10.1146/annurev.iy.13.040195.001055)
  20. Heinzel, F. P., R. M. Rerko, F. Ahmed, E. Pearlman. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155: 730 (10.4049/jimmunol.155.2.730)
  21. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, R. M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin-4 monoclonal antibody. J. Exp. Med. 171: 115 (10.1084/jem.171.1.115)
  22. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyan, S. J. Goldman, D. S. Sieburth, S. F. Wolf, R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177: 1793 (10.1084/jem.177.6.1797)
  23. Szabo, S. J., N. G. Jacobson, A. S. Dighe, U. Gubler, K. M. Murphy. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2: 665 (10.1016/1074-7613(95)90011-X)
  24. Wysocka, M., M. Kubin, L. Q. Viera, L. Ozmen, G. Garotta, P. Scott, G. Trinchieri. 1995. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25: 672 (10.1002/eji.1830250307)
  25. Keane-Myers, A., W. C. Gause, P. S. Linsley, S.-J. Chen, M. Wills-Karp. 1996. B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2 mediated allergic airway responses to inhaled antigens. J. Immunol. 158: 2042 (10.4049/jimmunol.158.5.2042)
  26. Trinchieri, G.. 1994. Interleukin-12: a cytokine produced by antigen presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84: 4008 (10.1182/blood.V84.12.4008.bloodjournal84124008)
  27. D’Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, G. Trinchieri. 1993. Interleukin-10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178: 1041 (10.1084/jem.178.3.1041)
  28. Golding, B., M. Zautseva, H. Golding. 1994. The potential for recruiting immune responses toward type-1 or type-2 help. Am. J. Trop. Med. Hyg. 50: 33 (10.4269/ajtmh.1994.50.33)
  29. Keane-Myers, A., S. P. Nickell. 1995. Role of IL-4 and IFN-γ in modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 155: 2020 (10.4049/jimmunol.155.4.2020)
  30. Rousset, F., J. Robert, M. Andary, J.-P. Bonin, G. Souillet, I. Chretien, F. Briere, J. Pene, J. E. D. Vries. 1991. Shifts in interleukin-4 and interferon-γ production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J. Allergy Clin. Immunol. 87: 58 (10.1016/0091-6749(91)90213-8)
  31. Gavett, S. H., D. J. O’Hearn, X. Li, S.-K. Huang, F. D. Finkleman, M. Wills-Karp. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182: 1527 (10.1084/jem.182.5.1527)
  32. Oswald, I. P., P. Caspar, D. Jankovic, T. A. Wynn, E. J. Pearce, A. Sher. 1994. IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni. J. Immunol. 153: 1707 (10.4049/jimmunol.153.4.1707)
  33. Kips, J. C., G. J. Brusselle, G. F. Joos, R. A. Peleman, J. H. Tavernier, R. R. Devos, R. A. Pauwels. 1996. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 153: 535 (10.1164/ajrccm.153.2.8564093)
  34. Marshall, J. D., H. Secrist, R. H. DeKruyff, S. F. Wolf, D. T. Umetsu. 1995. IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes. J. Immunol. 155: 111 (10.4049/jimmunol.155.1.111)
  35. Rankin, J. A., D. E. Picarella, G. P. Geba, U. A. Temann, B. Prasad, B. DiCosmo, A. Tarallo, B. Stripp, J. Whitsett, R. A. Flavell. 1996. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc. Natl. Acad. Sci. USA 93: 7821 (10.1073/pnas.93.15.7821)
  36. Lack, G., H. Renz, J. Saloga, K. L. Bradley, J. Loader, D. Y. M. Leung, G. Larsen, E. W. Gelfand. 1994. Nebulized but not parenteral IFN-γ decreases IgE production and normalized airways function in a murine model of allergen sensitization. J. Immunol. 152: 2546 (10.4049/jimmunol.152.5.2546)
  37. Li, X., R. K. Chopra, T. Chou, B. H. Schofield, M. Wills-Karp, S. Huang. 1996. Mucosal IFN-γ gene transfer inhibits pulmonary allergic responses in mice. J. Immunol. 157: 3216 (10.4049/jimmunol.157.8.3216)
  38. King, C. L., J. Hakimi, M. T. Shata, A. Medhat. 1995. IL-12 regulation of parasite antigen-driven IgE production in human helminth infections. J. Immunol. 155: 454 (10.4049/jimmunol.155.1.454)
  39. Kiniwa, M., M. Gately, U. Gubler, R. Chizzonite, C. Fargeas, G. Delespesse. 1992. Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J. Clin. Invest. 90: 262 (10.1172/JCI115846)
  40. Chvatchko, Y., M. H. Kosco-Vibois, S. Herren, J. Lefort, J.-Y. Bonnefoy. 1996. Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge. J. Exp. Med. 184: 2353 (10.1084/jem.184.6.2353)
  41. King, C. L., C. C. Low, T. B. Nutman. 1993. IgE production in human helminth infection: reciprocal interrelationship between interleukin-4 and interferon-γ. J. Immunol. 150: 1873 (10.4049/jimmunol.150.5.1873)
  42. Van der Pouw Kraan, T. C. T. M., L. C. Boeije, R. J. T. Smeenk, J. Wijdenes, L. A. Aarden. 1995. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181: 775 (10.1084/jem.181.2.775)
  43. Karp, C. L., M. Wysocka, L. M. Wahl, J. M. Ahearn, P. J. Cuomo, B. Sherry, G. Trinchieri, D. E. Griffin. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273: 228 (10.1126/science.273.5272.228)
  44. Launois, P., K. G. Swihart, G. Milon, J. A. Louis. 1997. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J. Immunol. 158: 3317 (10.4049/jimmunol.158.7.3317)
  45. Naseer, T., E. M. Minshall, D. Y. M. Leung, S. Laberge, P. Ernst, R. J. Martin, Q. Hamid. 1997. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am. J. Respir. Crit. Care Med. 155: 845 (10.1164/ajrccm.155.3.9117015)
Dates
Type When
Created 2 years, 8 months ago (Dec. 31, 2022, 9:20 a.m.)
Deposited 8 months ago (Jan. 2, 2025, 11:31 a.m.)
Indexed 3 months, 1 week ago (May 20, 2025, 2:04 p.m.)
Issued 27 years, 1 month ago (July 15, 1998)
Published 27 years, 1 month ago (July 15, 1998)
Published Print 27 years, 1 month ago (July 15, 1998)
Funders 0

None

@article{Keane_Myers_1998, title={Resistance to Antigen-Induced Airway Hyperresponsiveness Requires Endogenous Production of IL-12}, volume={161}, ISSN={1550-6606}, url={http://dx.doi.org/10.4049/jimmunol.161.2.919}, DOI={10.4049/jimmunol.161.2.919}, number={2}, journal={The Journal of Immunology}, publisher={Oxford University Press (OUP)}, author={Keane-Myers, Andrea and Wysocka, Maria and Trinchieri, Giorgio and Wills-Karp, Marsha}, year={1998}, month=jul, pages={919–926} }